Can CYP2C19 help with menopause?

CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel, proton pump inhibitors, and certain antidepressants. Regarding menopause, there is no direct, strong evidence that CYP2C19 variants significantly affect hormone levels or common symptoms such as hot flashes or mood changes. Some studies suggest CYP2C19 polymorphisms may modulate the efficacy of SSRIs (e.g., citalopram) occasionally used for hot flashes, but the effects are small and not clinically decisive. Hormone replacement therapy (HRT) is mainly metabolized by CYP1A2 and CYP3A4, not CYP2C19. Therefore, a CYP2C19 genetic test is not recommended for menopause management based on current evidence. The evidence base is unclear and relies on mechanistic reasoning rather than robust clinical trials. Consult a physician for menopausal symptoms before interpreting genetic test results.